Skip to main content
Chitra Lal
No Rating Available
(Learn About Our Rating System)

Chitra Lal, ATSF, FAASM, FACP, FCCP, MD

Languages spoken: English

Clinical Locations

Primary Location

Sleep Wake Center

Sleep Wake Services
1138 Wilmington Ave.
Salt Lake City , UT 84106

University of Utah Hospital

Medical Intensive Care Unit
50 N Medical Dr
Salt Lake City , UT 84132

Huntsman Cancer Institute - Cancer Hospital South

Medical Intensive Care Unit
1950 Circle of Hope
Salt Lake City , UT 84112

University of Utah Hospital

Pulmonary, Clinic 3
50 N Medical Dr
Salt Lake City , UT 84132
  • Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Sleep Medicine
    American Board of Internal Medicine (Sub: Sleep Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)
    American Board of Internal Medicine (Sub: Critical Care Medicine)
  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Professor (Clinical)
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Sleep Medicine
    American Board of Internal Medicine (Sub: Sleep Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)
    American Board of Internal Medicine (Sub: Critical Care Medicine)

    Education history

    Undergraduate Medicine, Surgery - Maulana Azad Medical College (MAMC), University of Delhi M.B.B.S.
    Residency Pediatrics, Diploma in Child Health - Maulana Azad Medical College (MAMC), University of Delhi Resident
    Residency Internal Medicine - St. Joseph Hospital Resident
    Fellowship Pulmonary/Critical Care/Sleep Medicine - University of Tennessee Health Science Center Fellow

    Selected Publications

    Journal Article

    1. Lal C, Barker J, Strange (2011). Unilateral pulmonary artery aplasia in a pregnant patient. Case reports in medicine, 2011, 806723. (Read full publication)
    2. Lal C, Strange C, Bachman (2012). Neurocognitive impairment in obstructive sleep apnea [Review]. Chest, 141(6), 1601-1610. (Read full publication)
    3. Lal C, Huggins JT, Sahn S (2013). Parasitic diseases of the pleura [Review]. The American journal of the medical sciences, 345(5), 385-9. (Read full publication)
    4. Bade BC, Strange C, Lal (2014). Effect of obstructive sleep apnea treatment on mail-in cognitive function screening instrument. The American journal of the medical sciences, 348(3), 215-8. (Read full publication)
    5. Lal C, White DR, Joseph JE, van Bakergem K, LaRosa (2015). Sleep-disordered breathing in Down syndrome [Review]. Chest, 147(2), 570-579. (Read full publication)
    6. Lal C, Siddiqi N, Kumbhare S, Strange (2015). Impact of medications on cognitive function in obstructive sleep apnea syndrome. Sleep & breathing = Schlaf & Atmung, 19(3), 939-45. (Read full publication)
    7. Lal C, Medarov BI, Judson M (2015). Interrelationship between sleep-disordered breathing and sarcoidosis [Review]. Chest, 148(4), 1105-1114. (Read full publication)
    8. Zhu X, Kelly TH, Curry TE Jr, Lal C, Joseph J (2015). Altered functional brain asymmetry for mental rotation: effect of estradiol changes across the menstrual cycle. Neuroreport, 26(14), 814-9. (Read full publication)
    9. Lal C, DiBartolo MM, Kumbhare S, Strange C, Joseph J (2016). Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women. Sleep & breathing = Schlaf & Atmung, 20(2), 621-6. (Read full publication)
    10. Balachandran JS, Thomson CC, Sumter DB, Shelgikar AV, Lachapelle P, Pamidi S, Fall M, Lal C, Baba RY, Shah N, Fields BG, Sarmiento K, Butler MP, Shea SA, Baptiste JV, Sharkey KM, Wang (2016). ATS Core Curriculum 2016: Part I. Adult Sleep Medicine. Annals of the American Thoracic Society, 13(4), 549-61. (Read full publication)
    11. D'Esposito CF, Farhood Z, Baker AB, Nguyen SA, LaRosa AC, Lal C, White D (2017). Assessment of weight gain following adenotonsillectomy in children with Down syndrome. International journal of pediatric otorhinolaryngology, 100, 103-106. (Read full publication)
    12. Lal C, Strange (2016). Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy [Review]. International journal of chronic obstructive pulmonary disease, 12, 135-140. (Read full publication)
    13. Abuzaid AS, Al Ashry HS, Elbadawi A, Ld H, Saad M, Elgendy IY, Elgendy A, Mahmoud AN, Mentias A, Barakat A, Lal (2017). Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea [Review]. The American journal of cardiology, 120(4), 693-699. (Read full publication)
    14. Lal C, Strange (2017). A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD [Review]. Expert opinion on pharmacotherapy, 18(17), 1833-1843. (Read full publication)
    15. Ong AA, Atwood CM, Nguyen SA, Teufel RJ 2nd, Lal C, LaRosa AC, White D (2018). Down syndrome and pediatric obstructive sleep apnea surgery: A national cohort. The Laryngoscope, 128(8), 1963-1969. (Read full publication)
    16. Lal C, Hardiman G, Kumbhare S, Strange (2019). Proteomic biomarkers of cognitive impairment in obstructive sleep apnea syndrome. Sleep & breathing = Schlaf & Atmung, 23(1), 251-257. (Read full publication)
    17. Lal C, Strange (2019). Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD). Expert opinion on pharmacotherapy, 20(9), 1075-1085. (Read full publication)
    18. Lal C, Kumbhare S, Strange (2020). Prevalence of self-reported sleep problems amongst adults with obstructive airway disease in the NHANES cohort in the United States. Sleep & breathing = Schlaf & Atmung, 24(3), 985-993. (Read full publication)
    19. Lal C, Khan (2020). Emerging Treatments for COPD: Evidence to Date on Revefenacin [Review]. COPD, 17(1), 112-119. (Read full publication)
    20. Strange C, Richard CL, Shan S, Phillips BA, Kanotra S, Drummond MB, Megenhardt L, Lal C, Pleasants R (2021). A population-based estimate of the health care burden of obstructive sleep apnea using a STOP-BAG questionnaire in South Carolina. Journal of clinical sleep medicine, 17(3), 367-374. (Read full publication)
    21. Lal C, Weaver TE, Bae CJ, Strohl K (2021). Excessive Daytime Sleepiness in Obstructive Sleep Apnea. Mechanisms and Clinical Management [Review]. Annals of the American Thoracic Society, 18(5), 757-768. (Read full publication)
    22. Lal C, Ayappa I, Ayas N, Beaudin AE, Hoyos C, Kushida CA, Kaminska M, Mullins A, Naismith SL, Osorio RS, Phillips CL, Parekh A, Stone KL, Turner AD, Varga A (2022). The Link between Obstructive Sleep Apnea and Neurocognitive Impairment: An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society, 19(8), 1245-1256. (Read full publication)
    23. Khan A, Clay RD, Singh A, Lal C, Tereshchenko L (2022). Ventricular Arrhythmias in Patients with Implanted Cardiac Devices at High Risk of Obstructive Sleep Apnea. Medicina (Kaunas, Lithuania), 58(6), (Read full publication)
    24. Steier JS, Bogan RK, Cano-Pumarega IM, Fleetham JA, Insalaco G, Lal C, Pépin JL, Randerath WJ, Redline S, Malhotra (2023). Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea - A Delphi consensus study [Review]. Sleep medicine, 112, 104-115. (Read full publication)
    25. Lal (2024). Obstructive Sleep Apnea and Sarcoidosis Interactions [Review]. Sleep medicine clinics, 19(2), 295-305. (Read full publication)
    26. Marrero-Gonzalez AR, Salvador CD, Nguyen SA, Meyer TA, Ford DW, Rinn AM, Lal C, Swanson M, Abdelwahab (2024). Depressive symptoms after surgical and medical management of OSA: a systematic review and meta-analysis. Sleep & breathing = Schlaf & Atmung, 29(1), 64. (Read full publication)

    Case Report

    1. McLeroy LD, Daly DD, Rier JD, Lal C, Fernandes V (2017). Pulmonary Embolism in Transit Before Pulseless Electrical Activity Arrest. The American journal of the medical sciences, 354(4), 436-437. (Read full publication)

    Editorial

    1. Lal (2017). Sleep-disordered Breathing and Cognitive Impairment: A Subtle but Important Association. Annals of the American Thoracic Society, 14(11), 1636-1637. (Read full publication)

    Letter

    1. Lal C, Weiman D, Eltorky M, Pugazhenthi (2005). Complete resolution of fibrosing mediastinitis with corticosteroid therapy. Southern medical journal, 98(7), 749-50. (Read full publication)

    Other

    1. Strollo PJ Jr, Hedner J, Collop N, Lorch DG Jr, Chen D, Carter LP, Lu Y, Lee L, Black J, Pépin JL, Redline S, Tones 4 Study Investigator (2019). Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study. Chest, 155(2), 364-374. (Read full publication)